 |
|
|
| |
Evaluation of NS3 Amino Acid Variants in a Phase 1b Study of GT 1 Infection with the HCV Protease Inhibitor, MK-5172
|
| |
| |
Reported by Jules Levin
19th CROI, Seattle, WA, March 5-8, 2012
Richard Barnard, Julie Strizki, Carolyn McHale, William Newhard,
Carol Cheney, Donald Graham, Amelia Petry, Robert Nachbar, Iain
Fraser, Daria Hazuda
|
| |
|
|
|
|
|
